乙型肝炎肝衰竭中医证候数据库的建立*

doi:10.3969/j.issn.1672-5069.2011.04.011

Abstract

Abstract: Objective To establish a prospective symptomatic survey database for patients with hepatitis B-induced hepatic failure. Method Nationwide inpatients with hepatitis B-induced hepatic failure coming from eighteen hospitals were surveyed and a database was established. Results A set of standardized information forms including inclusion and exclusion criteria were successfully established. A given patient's information could be entered and retrieved easily. A comprehensive analysis of the data could be conducted online. Conclusions The database is based on the clinical data especially on the traditional Chinese medicine involving four diagnostic information.

Key words: Hepatitis B, Hepatic failure, Chinese medicine symptom, database

LI Fengyi，WANG Lifu，ZHANG Xiaofeng，et al.. Establishment of symptomatic survey database for patients with hepatitis B-induced hepatic failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2011, 14(4): 270-272.

References

[1] FLISIAK R，PROKOPOWICZ D，JAROSZEWICZ J，et al. Plasma transforming growth factor beta（1）in acute viral hepatitis[J]. Med Sci Monit，2005，11（6）:CR304-CR308.
[2] 张定凤. 加强对重型肝炎的研究[J]. 中华肝脏病杂志，2006，14（9）：641-642.
[3] 王融冰，王宪波，孙凤霞，等. 解毒凉血法治疗乙型肝炎肝衰竭[J]. 北京中医药，2008，27（2）：83-84.
[4] ZHUANG Y，LI S，LI Y. dbNEI:A specific database for neuro-endocrine-immune interactions[J]. Neuro Endocrinol Lett，2006，27（1-2）:53-59.
[5] ZHUANG YL，MA F，LI LJ，et al. Comparative analysis of amino acids usage and protein length distribution between alternatively and non-alternatively spliced genes across six eukaryotic genomes[J]. Mol Biol Evolut，2003，20（12）:1978-1985.
[6] 庄永龙，马飞，周敏，等. 基于多Agent的生物信息数据整合系统-BioAgent1[J]. 电子学报，2005，33（1）:78-82.
[7] 邹正升，陈菊梅，辛绍杰，等. 乙型肝炎肝衰竭488例的临床研究[J]. 世界华人消化杂志，2001，9（7）:848-849．
[8] 陶夏平，周仲瑛，姚乃礼，等. 重型肝炎瘀热相搏证治探讨[J]. 中国中医基础医学杂志，2004，10(1):51-52.
[9] 毛德文. 肝衰竭毒邪病因学说辨析[J]. 中医药导报，2007，13（1）:8-11.
[10] 谌宁生，孙克伟. 试谈重型肝炎辨证论治之经验[J]. 中西医结合肝病杂志，2002，12（3）:163-164.
[11] 钱英，张秋云，李秀惠，等. 钱英教授治疗慢性病毒性重型肝炎经验介绍[J]. 新中医，2005，37（3）:14-15.
[12] 肖阁敏，关卫兵，戴敏，等. 乙型肝炎肝衰竭不同时段舌脉象的动态分析[J]. 传染病信息，2010，23（5）：279-281.
[13] 陈玮，刘政芳，林恢，等. 乙型肝炎肝衰竭中医辨证虚实属性与生化指标的相关性分析[J]. 传染病信息，2010，23（5）：273-275.
[14] 张秋云，李秀惠，王融冰，等. 慢性病毒性乙型重型肝炎中医证候分布及组合规律研究[J]. 北京中医药，2008，27（2）：87-90.
[15] 张宁，李筠. 慢性重型肝炎的中医证候规律研究进展[J]. 中西医结合肝病杂志，2009，19（3）：186-188.

Establishment of symptomatic survey database for patients with hepatitis B-induced hepatic failure

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[4]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[5]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[6]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[7]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[8]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[9]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[10]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[11]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[12]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[13]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[14]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[15]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.